Table 2. Real-Time Analysis of LRP Development without MS or after Cytokinin (Benzyl Adenine) Application.

MS		Cytokinin (2 µM Benzyl Adenine)
Progress of LRP Development After Application	No. of Events	Progress of LRP Development after Application	No. of Events
From I to I	1	From I to I	12
From I to II	3	From II to II	7
From I to III	5	From II to III	1
From I to IV	1	From I to IV	0
From I to V	1	From I to V	0
From II to II	1	From II to II	0
From II to III	1	From II to III	0
From II to IV	5	From II to IV	0
From II to V	1	From II to V	0
From II to Em	1	From II to Em	0
Fully arrested/total	2/20	Fully arrested/total	19/20
From III to III	1	From III to III	7
From III to V	1	From III to IV	2
From III to Em	2	From IV to IV	7
From IV to IV	1	From IV to V	1
From IV to VII	3	From IV to E	3
From IV to Em	6	From IV to Em	0
Fully arrested/total	2/14	Fully arrested/total	14/20
From V to VI	1	From V to VII	1
From V to VII	0	From V to Em	7
From V to Em	5	From VI to VII	1
From VI to Em	2	From VI to Em	1
Fully arrested/total	0/8	Fully arrested/total	0/10

Em, emergence.